MTOR and schizophrenia: In two different developmental rat models of schizophrenia specifically neonatal phencyclidine and postweaning isolation, the mammalian target of rapamycin (mTOR) pathway was found to be persistently upregulated in the prefrontal cortex (Meffre et al., 2012).